GlassScriptPhysician profile
Shray Nohria
NPI 1659755460
$3,032.45
in general payments reported to CMS, 2019-2025
16 companies · $984 in 2025
The $984 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $323 · 2021: $94.47 · 2022: $349 · 2023: $529 · 2024: $447 · 2025: $984.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,959.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,959.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $820.53 | 2019-2025 | Jardiance, Synjardy |
| Amgen INC. | $524.59 | 2024-2025 | Otezla, Repatha, Repatha |
| Novo Nordisk INC | $413.51 | 2020-2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $399.76 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $184.28 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $120.20 | 2024-2025 | Shingrix, Arexvy, Penmenvy |
| Merck Sharp & Dohme LLC | $119.67 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $117.25 | 2019-2020 | |
| Pfizer INC. | $105.39 | 2022-2025 | |
| Boston Scientific Corporation | $104.18 | 2019 | |
| Abbvie INC. | $24.60 | 2025 | |
| Tms Neurohealth Centers INC. | $22.73 | 2025 | Tms Neurohealth Centers INC. |
| Abbott Laboratories | $21.41 | 2022 | |
| Vanda Pharmaceuticals INC. | $20.13 | 2022 | |
| Dexcom, INC. | $19.64 | 2024 | Dexcom G6 Transmitter |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $14.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shray Nohria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.